TalkMed (SGX:5G3) appointed KPMG Corporate Finance as independent financial adviser for the proposed privatization of the company by way of a scheme of arrangement, according to a filing with the Singapore Exchange on Thursday.
In an earlier filing, TW Troy offered to acquire all the issued and paid-up shares in the company's capital by way of a scheme of arrangement.
TW Troy would pay or procure a payment of SG$0.456 in cash per scheme share held by shareholders.
Shares of the company gained over 1% in recent trade.
Price (SGD): S$0.45, Change: S$+0.0050, Percent Change: +1.12%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。